tiprankstipranks
Atomo Diagnostics Ltd. (AU:AT1)
ASX:AT1
Australian Market
Holding AU:AT1?
Track your performance easily

Atomo Diagnostics Ltd. (AT1) Income Statement

1 Followers

Atomo Diagnostics Ltd. Income Statement

Last quarter (Q4 2022), Atomo Diagnostics Ltd.'s total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Atomo Diagnostics Ltd.'s net income was AU$―. See Atomo Diagnostics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20
Total Revenue
-AU$ 12.34MAU$ 6.72MAU$ 1.97M
Cost of Revenue
-AU$ 8.09MAU$ 3.30MAU$ 2.17M
Gross Profit
-AU$ 4.25MAU$ 3.42MAU$ -202.34K
Operating Expense
-AU$ 12.72MAU$ 9.93MAU$ 7.44M
Operating Income
-AU$ -8.47MAU$ -6.51MAU$ -7.64M
Net Non Operating Interest Income Expense
-AU$ -10.01KAU$ 82.91KAU$ -5.26M
Other Income Expense
-AU$ 2.77MAU$ 405.54KAU$ 3.69M
Pretax Income
-AU$ -5.71MAU$ -6.02MAU$ -9.22M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
-AU$ -5.71MAU$ -6.02MAU$ -9.22M
Basic EPS
-AU$ -0.01AU$ -0.01AU$ -0.03
Diluted EPS
-AU$ -0.01AU$ -0.01AU$ -0.03
Basic Average Shares
-AU$ 568.95MAU$ 564.33MAU$ 355.36M
Diluted Average Shares
-AU$ 568.95MAU$ 564.33MAU$ 355.36M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
----
Net Income From Continuing And Discontinued Operation
-AU$ -5.71MAU$ -6.02MAU$ -9.22M
Normalized Income
-AU$ -5.71MAU$ -6.02MAU$ -9.22M
Interest Expense
-AU$ 15.47KAU$ 7.79KAU$ 5.29M
EBIT
-AU$ -5.69MAU$ -6.01MAU$ -3.93M
EBITDA
-AU$ -3.69MAU$ -4.70MAU$ -3.23M
Currency in AUD

Atomo Diagnostics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis